GW25-e3177 β2 adrenergic receptor selective agonist clenbuterol protects cardiac arrhythmia after reperfusion  by Qin, Fu
Objectives: Cardiovascular and renal remodeling is the major determinant of progress
of chronic cardiovascular and renal diseases. Our previous study demonstrated that
uncoupling protein 2 (UCP2) plays a protective role in salt-induced vascular
dysfunction via an antioxidative action. The aim of this study was to investigate the
effects of UCP2 on salt-induced cardiovascular and renal remodeling.
Methods: UCP2-knockout (KO) mice and wild-type (WT) littermates were fed with
normal-salt diet (NS, 0.5%) and high-salt diet (HS, 8%) for 16 weeks. The histology,
ﬁbrosis, superoxide, expressions of matrix metalloproteinase (MMP) -2/-3/-9 and
tissue inhibitor-1 of MMP (TIMP-1) in heart, aorta, mesenteric arterioles and kidneys
were evaluated.
Results: In WT mice, salt had little effect on cardiomyocyte size, but, in KO mice,
salt caused a signiﬁcant increase in cardiomyocyte size compared with NS group
(21721 vs. 33623 mm2, P<0.01). As expected, salt-fed animals from both
genotypes were found to have a signiﬁcant ﬁbrosis (both P<0.01). Interestingly, KO
mice showed greater ﬁbrosis after a salt intake compared with WT mice (20.82.3%
vs. 8.41.6%, P<0.01). The wall thickness of both aorta and mesenteric arterioles
were increased signiﬁcantly due to salt-treated WT mice (both P<0.01) but were
signiﬁcantly higher in KO mice (aorta: 1017 vs. 826 mm, P<0.05; mesenteric
arterioles: 11.41 vs 8.60.8 mm, P<0.05). High-salt intake greatly increased aortic
and mesenteric arteriolar ﬁbrosis in both genotypes (both P<0.01), while had a
signiﬁcantly higher effect in KO mice (P<0.01 for aorta, P<0.05 for mesenteric
arterioles). The high-salt diet resulted in no signiﬁcant changes in glomerular and
tubular size in WT mice, but a signiﬁcant increase in KO mice (P<0.01 for tuft area,
P<0.05 for tubular area). After 16 weeks of salt feeding, the glomerular tuft area in
KO mice was signiﬁcantly increased compared with WT mice (4.50.5 vs. 2.80.3
mm2, P<0.01). The salt administration caused a remarkably renal ﬁbrosis in both
genotypic mice (both P<0.01), while the salt-induced renal ﬁbrosis was exacerbated
KO mice compared with WT mice (34.25.1 vs. 12.52.2%, P<0.01). Fluorescence
assay showed that salt-induced superoxide production in heart, aorta and kidney
tissues were elevated in UCP2 KO mice compared with WT littermates (all P<0.01).
The cardiovascular and renal remodeling in both genotypes was accompanied by
increased MMP-2/-3/-9 and decreased TIMP-1 protein expression compared with
control groups (all P<0.01).
Conclusions: These data suggest that upregulation of UCP2 may attenuate the
development of salt-induced cardiovascular and renal damage.
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Objectives: The present study was undertaken to observe the effects of the chronic
adventitia injury on angiotensin II type 2 Receptor (AT2R) expression in the rat
carotid artery.
Methods: Adventitia injury was induced by positioning a silicone collar around the
right carotid artery for one week in 20 Wistar Kyoto rats. Both side of carotid was
harvested for analysis of AT2R expression. The expression of AT2R mRNA and
protein was assessed by RT-PCR and western bloting respectively. The expression
distribution of AT2R protein was assessed by immunohistochemistry.
Results: The AT2R mRNA expression increased 76% (P¼0.0061) and the AT2R
protein expression increased 3.37 fold (P<0.0001) respectively in the collared right
carotid artery when compared to non-collared left carotid artery. Immunohistochem-
ical examination revealed that there was little AT2R expression anywhere in the non-
collared left carotid artery and there was highly AT2R expression in intima and
adventitia but not in media in the collared right carotid artery.
Conclusions: The expression of AT2R mRNA and protein was upregulated in
response to the collar placement. Collar-induced adventitia injury leaded to
re-expression of AT2R in intima and adventitia of the rat carotid artery.
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Objectives: Our Previous study has demonstrated that b2 adrenergic receptor (b2AR)
activation reduces infarct size and myocardial apoptosis after myocardial ischemia/
reperfusion. Cardiac arrhythmias are a major manifestation of reperfusion injury,
which results in sudden death in acute myocardial infarction. The present study is
designed to investigate whether b2AR agonist clenbuterol will protect cardiac
arrhythmias induced by reperfusion.
Methods: Reperfusion arrhythmias were induced by 10 min ligation of the left
anterior descending coronary artery, followed by a 30 min reperfusion in anaesthetized
rats. Electrocardiogram (ECG) in Lead II conﬁguration was monitored throughout the
I/R process. Cardiac damage was characterized by a higher incidence of reperfusion-
induced ventricular tachycardia (VT) and ventricular ﬁbrillation (VF).JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BResults: The incidence and severity of cardiac arrhythmias were signiﬁcantly reduced
by pretreatment with b2AR agonist clenbuterol in anesthetized rats. The protective
effect of clenbuterol was attenuated by a selective b2AR antagonist ICI 118,551 or a
gap-junction protein connexin (CX) inhibitor cabenoxolone. Clenbuterol also reduced
the dephosphorylation and redistribution of Connexin 43 (CX43) induced by
ischemia/reperfusion. Furthermore, pretreatment with clenbuterol signiﬁcantly
inhibited dephosphorylation of CX43 in isolated wild type not b2AR-knock out mouse
hearts after ischemia/reperfusion injury.
Conclusions: These data demonstrated that b2AR agonist clenbuterol provides sig-
niﬁcant protection against arrhythmias induced by reperfusion, which is likely
mediated at least in part by reducing dephosphorylation and redistribution of CX43,
thereby enhancing the gating function of gap junctions in heart.
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Objectives: To investigate the effect of puerarin, a kind of Chinese herbal medicine,
on cardiomyoblast inﬂammatory response in a sepsis model using LPS.
Methods: H9c2 cardiomyoblasts were incubated with different concentrations of
puerarin (1mM, 5mM, 10mM, 20mM, 40mM) in the presence of LPS (1mg/mL) or not.
The mRNA expression of inﬂammatory cytokine including IL-1, IL-6 and TNFa were
detected using real-time PCR. Immunoﬂuorescent staining was used to evaluate NFkB
p65 nuclear translocation. LPS-induced apoptosis was measured by TUNEL staining
and immunoblotting of Bcl-2 and Bax expression. The activation state of NFkB
signaling was investigated using Western Blotting.
Results: Puerarin blunted proinﬂammatory cytokine production in LPS-stimulated
H9c2 cardiomyoblasts in a concentration dependent manner. In addition, treatment of
H9c2 cardiomyoblasts with puerarin (40mM) inhibited LPS-induced apoptosis.
Moreover, the NFkB p65 nuclear translocation and activation of NFkB signaling after
LPS stimulation were suppressed by puerarin (40mM).
Conclusions: Puerarin may serve as a valuable protective agent in cardiovascular
inﬂammatory diseases.
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Objectives: Coronary no reﬂow (NR) phenomenon of varying degrees widely exists
in patients undergoing coronary artery recanalization therapy with type 2 diabetes
mellitus (T2DM) signiﬁcantly increasing the severity of it. Meanwhile, plasma adi-
ponectin (APN) level is signiﬁcantly reduced in patients with T2DM. To demonstrate
whether hypoadiponectinemia could lead to aggravated coronary NR injury in T2DM
and the protective effect of APN on coronary microcirculation, we conducted the
following experiments.
Methods: Healthy male SD rats of 6-week-old were fed with normal diet (10kcal
%, ND) or high-fat and high-sugar diet (60kcal%, HD). All rats were fed
continuously for 32 weeks. Body weight, fasting glucose, fasting insulin and
serum APN levels were monitored regularly. 8 weeks later, intraperitoneal in-
jections of glucose tolerance test (IPGTT) were performed every 4 weeks. And
abnormal IPGTT was selected as a measurement for successful model of type 2
diabetes. Successfully fed type 2 diabetic rats and normal rats were divided into 4
groups: Sham group; normal control group (ND); diabetic rats group (DM);
diabetic rats+globular adiponectin (gAd) intervention group (DM+gAd); gAd of
20mg/kg or 0.5ml of saline solution were injected into rats via tail vein at the 31st
weekend. In each group, ischemia was produced via left anterior descending
coronary artery slip-knot ligation for 1.5hours and then reperfusion for 12 hours.
No reﬂow injury areas were measured using Evan’s Blue and Thioﬂavin S
staining methods. The reperfusion areas of myocardial microcirculation were
showed with ﬂuorescent microspheres. Left ventricular pressure was measured to
evaluate cardiac function of rats. Serum adiponectin (APN), endothelin-1 (ET-1),
intercellular adhesion molecule-1 (ICAM-1) and vascular endothelial adhesion
molecule-1 (VCAM-1) levels were measured simultaneously to assess vascular
endothelial injury.
Results: (1) Serum adiponectin levels of diabetic rats increased ﬁrstly and then
continued to reduce in the process of HD feeding. ET-1, ICAM-1, VCAM-1 in both
DM group and DM+gAd group were signiﬁcantly increased in the 32th weekend.
After administration of gAd, ET-1 was signiﬁcantly reduced (108.6.138.428
vs.132.107.213, P<0.05). (2) NR injury in DM group was increased after I/R
(48.642.93% vs. 35.484.31%, P< 0.05). Cardiac function showed obviously
impaired (+dp/dt: 2514.36188.93 vs.3714.73118.90, P<0.01) with increased serum
levels of ICAM-1 and VCAM-1.3) NR injury (28.481.441% vs 48.641.928%,
P<0.01) and cardiac function after I/R injury in DM+gAd group improved signiﬁcantly
(+dp/dt: 3280.18192.84 vs.2514.36188.93, P<0.01) with decreased serum
ICAM-1 and VCAM-1 levels.asic and Translational Medicine C49
